Evidence map›Paper›PMID 29333922›Full record

ArticleIslets2018

Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice.

Eun-Mi Lee, Inwon Park, Ye-Jee Lee, Young-Hye You, Ji-Won Kim, Myung-Jun Kim, Yu-Bae Ahn, Pilhan Kim, Seung-Hyun Ko

Open access · bronzeAbstract read
In one paragraph

Article in Islets, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Biomedical optics express · 2023
    Article
  6. Anti-Oxidative Therapy in Islet Cell Transplantation.Antioxidants (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eun-Mi Leea Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
Inwon Parkb Graduate School of Medical Science and Engineering , Korea Advanced Institute of Science and Technology , Daejeon , Republic of Korea.ORCID 0000-0001-7525-9189
Ye-Jee Leea Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
Young-Hye Youa Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
Ji-Won Kima Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
Myung-Jun Kimc Department of Physiology , College of Medicine, The Catholic University of Korea , Seoul , Republic of Korea.
Yu-Bae Ahna Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.
Pilhan Kimd Graduate School of Nanoscience and Technology , Korea Advanced Institute of Science and Technology , Daejeon , Republic of Korea.
Seung-Hyun Koa Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Republic of Korea.ORCID 0000-0003-3703-1479
The Catholic University of Korea St. Vincent's Hospital · KRKorea Advanced Institute of Science and Technology · KRCatholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the effect of resveratrol (RSV) on graft survival after islet transplantation (ITx) in diabetic mice. Isolated islets from Balb/c mice (200 IEQ) were transplanted under the kidney capsule of diabetic Balb/c mice. Vehicle or RSV (200 mg/kg/day, orally) was given for 14 days after ITx. Two more control groups [STZ-treated (No-ITx-Control) and STZ+RSV-treated (No-ITx-RSV) mice without ITx] were added. Glucose tolerance tests (GTT) was performed at 14 days after ITx. In vitro, isolated islets pretreated with vehicle or RSV (1 μM) were incubated in a hypoxic chamber (O

Indexed as

Islets of Langerhans TransplantationAnimalsCells, CulturedChemotherapy, AdjuvantCombined Modality TherapyDiabetes Mellitus, ExperimentalGraft SurvivalIslets of LangerhansMaleMiceMice, Inbred BALB CMice, TransgenicNeovascularization, PhysiologicResveratrolStreptozocinResveratrolStreptozocinDiabetesgraft survivalin vivo imagingislet transplantationoxidative stressresveratrolrevascularization

Identifiers

PMID29333922
PMCPMC5800387
OpenAlexW2783525693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.